These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
635 related articles for article (PubMed ID: 16706551)
21. Optimizing treatment outcomes in HIV-infected patients with substance abuse issues. Celentano DD; Lucas G Clin Infect Dis; 2007 Dec; 45 Suppl 4():S318-23. PubMed ID: 18190306 [TBL] [Abstract][Full Text] [Related]
22. Improving health outcomes among individuals with HIV, mental illness, and substance use disorders in the Southeast. Whetten K; Reif S; Ostermann J; Pence BW; Swartz M; Whetten R; Conover C; Bouis S; Thielman N; Eron J AIDS Care; 2006; 18 Suppl 1():S18-26. PubMed ID: 16938671 [TBL] [Abstract][Full Text] [Related]
23. Harmful alcohol consumption and patterns of substance use in HIV-infected patients receiving antiretrovirals (ANRS-EN12-VESPA Study): relevance for clinical management and intervention. Michel L; Carrieri MP; Fugon L; Roux P; Aubin HJ; Lert F; Obadia Y; Spire B; AIDS Care; 2010 Sep; 22(9):1136-45. PubMed ID: 20824566 [TBL] [Abstract][Full Text] [Related]
24. The HIV epidemic among individuals with mental illness in the United States. Weiser SD; Wolfe WR; Bangsberg DR Curr HIV/AIDS Rep; 2004 Dec; 1(4):186-92. PubMed ID: 16091241 [TBL] [Abstract][Full Text] [Related]
25. Management of psychiatric disorders in patients infected with human immunodeficiency virus. Angelino AF; Treisman GJ Clin Infect Dis; 2001 Sep; 33(6):847-56. PubMed ID: 11512090 [TBL] [Abstract][Full Text] [Related]
26. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes. Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408 [TBL] [Abstract][Full Text] [Related]
27. The impact of mental health and substance abuse factors on HIV prevention and treatment. Walkup J; Blank MB; Gonzalez JS; Safren S; Schwartz R; Brown L; Wilson I; Knowlton A; Lombard F; Grossman C; Lyda K; Schumacher JE J Acquir Immune Defic Syndr; 2008 Mar; 47 Suppl 1():S15-9. PubMed ID: 18301129 [TBL] [Abstract][Full Text] [Related]
28. Prevalence and co-occurrence of symptoms of mental and substance use disorders among people with HIV age 40 and older in low- and middle-income countries: a cross-sectional study. Parcesepe AM; Stockton M; Bernard C; Kanguya T; Kwobah EK; Lopez A; Murenzi G; Ross J; Minga A; Maruri F; Tlali M; Goodrich S; Perazzo H; Musabyimana F; Nimkar S; Lancaster K; Consortium I J Int AIDS Soc; 2024 Oct; 27(10):e26359. PubMed ID: 39375051 [TBL] [Abstract][Full Text] [Related]
29. Health Outcomes of HIV-Infected People with Mental Illness. Yehia BR; Stephens-Shield AJ; Momplaisir F; Taylor L; Gross R; Dubé B; Glanz K; Brady KA AIDS Behav; 2015 Aug; 19(8):1491-500. PubMed ID: 25931243 [TBL] [Abstract][Full Text] [Related]
30. Impact of depression on HIV outcomes in the HAART era. Hartzell JD; Janke IE; Weintrob AC J Antimicrob Chemother; 2008 Aug; 62(2):246-55. PubMed ID: 18456650 [TBL] [Abstract][Full Text] [Related]
31. Mental disorders and drug abuse in persons living with HIV/AIDS. Klinkenberg WD; Sacks S; AIDS Care; 2004; 16 Suppl 1():S22-42. PubMed ID: 15736820 [TBL] [Abstract][Full Text] [Related]
32. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART). Rothbard AB; Lee S; Blank MB J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006 [TBL] [Abstract][Full Text] [Related]
33. The validity of the Substance Abuse and Mental Illness Symptom Screener (SAMISS) in people living with HIV/AIDS in primary HIV care in Cape Town, South Africa. Breuer E; Stoloff K; Myer L; Seedat S; Stein DJ; Joska JA AIDS Behav; 2014 Jun; 18(6):1133-41. PubMed ID: 24452497 [TBL] [Abstract][Full Text] [Related]
34. Patient-related risks for nonadherence to antiretroviral therapy among HIV-infected youth in the United States: a study of prevalence and interactions. Rudy BJ; Murphy DA; Harris DR; Muenz L; Ellen J; AIDS Patient Care STDS; 2009 Mar; 23(3):185-94. PubMed ID: 19866536 [TBL] [Abstract][Full Text] [Related]
35. Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals. Lucas GM Life Sci; 2011 May; 88(21-22):948-52. PubMed ID: 20888839 [TBL] [Abstract][Full Text] [Related]
36. HIV infection and psychiatric illness. Owe-Larsson B; Säll L; Salamon E; Allgulander C Afr J Psychiatry (Johannesbg); 2009 May; 12(2):115-28. PubMed ID: 19582313 [TBL] [Abstract][Full Text] [Related]
37. Mental health disorders and the risk of AIDS-defining illness and death in HIV-infected veterans. Nurutdinova D; Chrusciel T; Zeringue A; Scherrer JF; Al-Aly Z; McDonald JR; Overton ET AIDS; 2012 Jan; 26(2):229-34. PubMed ID: 22089375 [TBL] [Abstract][Full Text] [Related]
38. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program. Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117 [TBL] [Abstract][Full Text] [Related]
39. The Important Role of Mental Illness and Substance Abuse in Successful Management of HIV Infection. Brion J; Kemppainen J J Assoc Nurses AIDS Care; 2017; 28(2):181-184. PubMed ID: 28236902 [No Abstract] [Full Text] [Related]
40. Substance abuse treatment in persons with HIV/AIDS: challenges in managing triple diagnosis. Durvasula R; Miller TR Behav Med; 2014; 40(2):43-52. PubMed ID: 24274175 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]